Merck & Company, Inc. Price Today
Merck & Company, Inc.
MRK
Healthcare
$266.43B
💰
Market Cap
20.5
💸
Price to Earnings
$5.1
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
15 |
Strong Buy |
9 |
Hold |
9 |
Sell |
0 |
Strong Sell |
0 |
MRK Price Forecast Target
105.0 👉 122.4 +17%
MRK EPS Forecast
5.1 👉 7.7 +50%
Financials
Profit Margin
5 %
Revenue Growth
3.0 %
Dividend
$ 2.92
Held Percent
0.1% - Insiders
77.6% - Institutions
22.3% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $26.0B
-
💰 Blackrock Inc. $22.2B
-
💰 State Street Corporation $12.4B
-
💰 Wellington Management Group, LLP $7.3B
-
💰 Geode Capital Management, LLC $5.4B
Stock Ideas
Steven Cohen Portfolio
Steven Cohen, the legendary trader and billionaire founder of Stamford-based SAC Capital, has established himself as a force to be reckoned with in the hedge fund industry. With a staggering net worth of $8 billion and an impressive $14 billion in …
Michael Platt Portfolio
Michael Platt is the founder and CEO of BlueCrest Capital Management, a global macro hedge fund with a focus on systematic trading strategies. Prior to starting BlueCrest, Platt worked as a portfolio manager and trader, gaining experience across glo…
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
Ray Dalio Portfolio
Ray Dalio, a visionary entrepreneur and investment strategist, laid the foundation of Bridgewater with a clear vision in mind. His relentless pursuit of excellence, coupled with an unwavering commitment to innovation, has propelled Bridgewater to be…📮FAQ
Some Frequently Asked Questions.
The Merck & Company, Inc. industry is Drug Manufacturers—General
The Merck & Company, Inc. sector is Healthcare
The Merck & Company, Inc. forecasted predicted Price to Earnings PE ratio is 13.7
The Merck & Company, Inc. Price to Earnings PE ratio is 20.5
The Market Capitalization of Merck & Company, Inc. is $266.43B
There are total of 2534441780 float shares with 77.6% held by Institutions and 0.1% held by insiders
The MMerck & Company, Inc. forecasted Earnings per Share EPS is $7.7
The Merck & Company, Inc. Earnings per Share EPS is 5.1
The Merck & Company, Inc. company has $42077000000 gross profits with 5 profit margins
The Merck & Company, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Merck & Company, Inc. Revenue is $58311000064 with 0.03 revenue growth
The price target for Merck & Company, Inc. stock is $122.4 for the high target and $99.8 for the low target
The consensus analyst recommendations for Merck & Company, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Merck & Company, Inc. is Buy, with the following breakdown:
- Buy: 15
- Strong Buy: 9
- Hold: 9
- Sell: 0
- Strong Sell: 0
The Beta of Merck & Company, Inc. is 0.3
The dividend of Merck & Company, Inc. is $2.92
The dividend yield of Merck & Company, Inc. is 0.0278%
The biggest institutional and mutual fund holders of Merck & Company, Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
- Wellington Management Group, LLP
The Merck & Company, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0